The Role of Immunometabolism in the Pathogenesis of Systemic Lupus Erythematosus

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Feb 14

PMID 35154082

Authors

George Anthony Robinson

Meredyth G Ll Wilkinson

Chris Wincup

Affiliations

Soon will be listed here.

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder in which pathogenic abnormalities within both the innate and adaptive immune response have been described. In order to activated, proliferate and maintain this immunological response a drastic upregulation in energy metabolism is required. Recently, a greater understanding of these changes in cellular bioenergetics have provided new insight into the links between immune response and the pathogenesis of a number of diseases, ranging from cancer to diabetes and multiple sclerosis. In this review, we highlight the latest understanding of the role of immunometabolism in SLE with particular focus on the role of abnormal mitochondrial function, lipid metabolism, and mTOR signaling in the immunological phenomenon observed in the SLE. We also consider what implications this has for future therapeutic options in the management of the disease in future.

Citing Articles

CD38 deficiency leads to a defective short-lived transcriptomic response to chronic graft-versus-host disease induction, involving purinergic signaling-related genes and distinct transcriptomic signatures associated with lupus.

Zubiaur M, Terron-Camero L, Gordillo-Gonzalez F, Andres-Leon E, Barroso-Del Jesus A, Canet-Antequera L Front Immunol. 2025; 16:1441981.

PMID: 39995666 PMC: 11847871. DOI: 10.3389/fimmu.2025.1441981.

Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosus.

Ueno M, Iwata S, Yamagata K, Todoroki Y, Sonomoto K, Nagayasu A RMD Open. 2024; 10(4.

PMID: 39740932 PMC: 11749818. DOI: 10.1136/rmdopen-2024-004567.

A review on the novel biomarkers of systemic lupus erythematosus discovered via metabolomic profiling.

Liu Y, Yang X Front Immunol. 2024; 15:1443440.

PMID: 39569194 PMC: 11576423. DOI: 10.3389/fimmu.2024.1443440.

Comparison of Metabolic Syndrome, Autoimmune and Viral Distinctive Inflammatory Related Conditions as Affected by Body Mass Index.

Chero-Sandoval L, Martinez-Urbistondo M, Cuevas-Sierra A, Higuera-Gomez A, Martin-Domenech E, Castejon R J Clin Med. 2024; 13(21).

PMID: 39518437 PMC: 11547109. DOI: 10.3390/jcm13216298.

Lupus Nephritis from Pathogenesis to New Therapies: An Update.

Roveta A, Parodi E, Brezzi B, Tunesi F, Zanetti V, Merlotti G Int J Mol Sci. 2024; 25(16).

PMID: 39201667 PMC: 11354900. DOI: 10.3390/ijms25168981.

References

Hahn B, Grossman J, Chen W, McMahon M . The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun. 2007; 28(2-3):69-75. DOI: 10.1016/j.jaut.2007.02.004. View

Gerriets V, Rathmell J . Metabolic pathways in T cell fate and function. Trends Immunol. 2012; 33(4):168-73. PMC: 3319512. DOI: 10.1016/j.it.2012.01.010. View

Tas S, Quartier P, Botto M, Fossati-Jimack L . Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells. Ann Rheum Dis. 2005; 65(2):216-21. PMC: 1798004. DOI: 10.1136/ard.2005.037143. View

Cairoli E, Rebella M, Danese N, Garra V, Borba E . Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect. Lupus. 2012; 21(11):1178-82. DOI: 10.1177/0961203312450084. View

Fernandez D, Bonilla E, Mirza N, Niland B, Perl A . Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arthritis Rheum. 2006; 54(9):2983-8. PMC: 4034146. DOI: 10.1002/art.22085. View

Bakshi J, Tejera Segura B, Wincup C, Rahman A . Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. Clin Rev Allergy Immunol. 2017; 55(3):352-367. PMC: 6244922. DOI: 10.1007/s12016-017-8640-5. View

Li H, Adamopoulos I, Moulton V, Stillman I, Herbert Z, Moon J . Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells. Nat Commun. 2020; 11(1):2859. PMC: 7275084. DOI: 10.1038/s41467-020-16636-4. View

Becker Y, Marcoux G, Allaeys I, Julien A, Loignon R, Benk-Fortin H . Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA. Front Immunol. 2019; 10:1026. PMC: 6524553. DOI: 10.3389/fimmu.2019.01026. View

Duvvuri B, Pachman L, Morgan G, Khojah A, Klein-Gitelman M, Curran M . Neutrophil Extracellular Traps in Tissue and Periphery in Juvenile Dermatomyositis. Arthritis Rheumatol. 2019; 72(2):348-358. DOI: 10.1002/art.41078. View

10.

Nagy G, Koncz A, Perl A . T cell activation-induced mitochondrial hyperpolarization is mediated by Ca2+- and redox-dependent production of nitric oxide. J Immunol. 2003; 171(10):5188-97. PMC: 4078644. DOI: 10.4049/jimmunol.171.10.5188. View

11.

Hajime Sumikawa M, Iwata S, Zhang M, Miyata H, Ueno M, Todoroki Y . An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus. Rheumatology (Oxford). 2021; 61(7):3049-3059. DOI: 10.1093/rheumatology/keab824. View

12.

Li W, Sivakumar R, Titov A, Choi S, Morel L . Metabolic Factors that Contribute to Lupus Pathogenesis. Crit Rev Immunol. 2016; 36(1):75-98. PMC: 5278665. DOI: 10.1615/CritRevImmunol.2016017164. View

13.

Menon M, Blair P, Isenberg D, Mauri C . A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus. Immunity. 2016; 44(3):683-697. PMC: 4803914. DOI: 10.1016/j.immuni.2016.02.012. View

14.

Lai Z, Hanczko R, Bonilla E, Caza T, Clair B, Bartos A . N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2012; 64(9):2937-46. PMC: 3411859. DOI: 10.1002/art.34502. View

15.

Kis-Toth K, Tsokos G . Dendritic cell function in lupus: Independent contributors or victims of aberrant immune regulation. Autoimmunity. 2010; 43(2):121-30. DOI: 10.3109/08916930903214041. View

16.

Pan L, Yang S, Wang J, Xu M, Wang S, Yi H . Inducible nitric oxide synthase and systemic lupus erythematosus: a systematic review and meta-analysis. BMC Immunol. 2020; 21(1):6. PMC: 7027241. DOI: 10.1186/s12865-020-0335-7. View

17.

Ryu H, Kim J, Kim D, Lee J, Chung Y . Cellular and Molecular Links between Autoimmunity and Lipid Metabolism. Mol Cells. 2019; 42(11):747-754. PMC: 6883973. DOI: 10.14348/molcells.2019.0196. View

18.

Huss J, Garbacz W, Xie W . Constitutive activities of estrogen-related receptors: Transcriptional regulation of metabolism by the ERR pathways in health and disease. Biochim Biophys Acta. 2015; 1852(9):1912-27. DOI: 10.1016/j.bbadis.2015.06.016. View

19.

Yu H, Chen P, Yang Y, Wang L, Lee J, Lin Y . Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study. Atherosclerosis. 2015; 243(1):11-8. DOI: 10.1016/j.atherosclerosis.2015.08.030. View

20.

Yin Y, Choi S, Xu Z, Perry D, Seay H, Croker B . Normalization of CD4+ T cell metabolism reverses lupus. Sci Transl Med. 2015; 7(274):274ra18. PMC: 5292723. DOI: 10.1126/scitranslmed.aaa0835. View